Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10
- 31 December 2004
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 113 (3-4) , 205-209
- https://doi.org/10.1016/j.thromres.2004.03.004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous ThromboembolismAnnals of Internal Medicine, 2003
- Comparison of Oral vs Intravenous Phytonadione (Vitamin K1) in Patients With Excessive AnticoagulationArchives of internal medicine (1960), 2003
- Prevention of Venous ThromboembolismChest, 2001
- Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trialThe Lancet, 2000
- Multicentre randomised study of computerised anticoagulant dosageThe Lancet, 1998
- Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin ∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/The American Journal of Medicine, 1998
- Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to WarfarinThrombosis and Haemostasis, 1998
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)The Lancet, 1996
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionThe American Journal of Medicine, 1993